Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Mov Disord. 2014 Dec 1;30(3):402–406. doi: 10.1002/mds.26084
Stock Ownership in medically-related fields: none Intellectual Property Rights: none
Consultancies: Addex Pharma, Advanced Studies of Medicine, Boston Scientific, CHDI, Clarion Healthcare, Partners, Frankel Group, Health ICON Clinical Research, Ingenix (i3 Research), National Institutes of Health Expert Testimony: none
Advisory Boards: Addex Pharma, Advanced Studies of Medicine, Boston Scientific, CHDI, Clarion Healthcare, Partners, Frankel Group, Health ICON Clinical Research, Ingenix (i3 Research), National Institutes of Health Employment: Rush University Medical Center
Partnerships Contracts: None
Honoraria: American Academy of Neurology, Movement Disorder Society, New York Academy of Medicine, Phipps University, Marburg, Germany, University of Pennsylvania Royalties: Royalties: Oxford University Press, Elsevier Publishers, Wolters Kluwer Health, Lippincott, Wilkins and Williams.
Other:
Grants: Michael J. Fox Foundation, NIH. Dr. Goetz directs the Rush Parkinson’s Disease Research Center that receives support from the Parkinson’s Disease Foundation. He directs the translation program for the MDS-UPDRS and UDysRS and receives funds from the MDS for this effort.